期刊文献+

高脂膳食大鼠血脂和脂质过氧化的变化及灵芝多糖的干预作用 被引量:2

Effects of Ganoderma Lucidum polysaccharides on serum Lipids and lipoperoxidation in Erperimental hyper Lipidemic rats
下载PDF
导出
摘要 目的观察不同剂量的灵芝多糖对高脂血症大鼠的血脂及抗氧化功能的影响。方法50只大鼠随机分成5组正常组、高血脂组和不同浓度灵芝多糖处理组,除正常组外,其它组的大鼠采用高脂食物喂养1个月后,鼠尾采血测定TC、TG含量,GSH-Px和SOD活性及MDH含量。结果灵芝多糖能明显降低TC、TG和LD的浓度(P<0.01),同时,灵芝多糖能明显提高血液GSH-Px和SOD酶活性(P<0.01),降低血液MDA的浓度(P<0.05)。结论灵芝多糖能调节大鼠高脂血症的脂代谢和增强抗脂质过氧化的作用。 Objective:To investigate the effect of Ganoderma Lucidum polysaccharides on blood lipid and Lipoperoxidation from the experimental hyperlipidemic rats.Methods:50 rats were randomly divided into normal group,Hyperlipidemia control,200mg/kg and 400mg/kg and 800mg/kg ganoderma Lucidum polysaccharides groups,A part from the tats in control group,the rats in other groups were fed with high fat forage for 30 days,The blood of rat-tait was to determine the Levels of TC,TG,GSH-Px,SOD and MDA.Results:Ganoderma Lucidum polysaccharides could signiticantly decrease the contants of TC,TG in the serum of the experimental hyperLipidemic rats (P<0.01),and mean Level of blood MDA in groups of Ganoderma Lacidum polysaccharides was much lower than that in hyper lipidema group,and the GSH-Px and SOD activities of blood in the group of Ganoderma was much higher than that in Hyperlipidema group.Conclusion:Ganoderma has the effects of regulating Lipid metabolism of hyperidemia and of enhancing the antioxidation and reducing the lipid peroxidaition.
出处 《中医药学报》 CAS 2005年第3期55-56,i001,共3页 Acta Chinese Medicine and Pharmacology
关键词 灵芝多糖 高脂血症 血脂 脂质过氧化 Ganoderma Hyerlipidemia Serum lipids Lipo peroxidation
  • 相关文献

参考文献8

二级参考文献29

  • 1孙庆杰.可溶性膳食纤维资源车前草的开发[J].食品研究与开发,1997,18(1):28-29. 被引量:7
  • 2Castelli WP, Anderson K, Wilson PW, Levy D, Lipids and risk of coronary heart disease: the Framingham Study. Ann Epidemiol 1992; 2 ( 1 - 2) : 23 - 8.
  • 3Wierzbicki AS, Milchailidis DP, Beyond LDL-C-the importance of raising HDL-C.Curr Med Res Opin 2002:18(1):36-44.
  • 4Hokanson JE. Hypertriglyceridemia and risk of coronary heart disease. Curr Cardiol Rep 2002; 4 (6) : 488 - 93.
  • 5Clearfield MB. The national cholesterol education program adult treatment panel ill guidelines. J Am Osteopath Assoc 2003; 103(1 Suppl 1): 1 -5.
  • 6Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) . JAMA 2001; 285(19):2486 - 97.
  • 7Packard C, Nunn A, Hobbs R. Futme Forum Editorial Board. High density Lipoprotcin: guardian of the vascular system? Int J Clin Pract 2002; 56(10):761 -71.
  • 8Barbagallo CM, Polizzi F, Severino M, et al. Distribution of risk factors, plasma lipicls, lipoproteins and dyslipidemias in a small Mediterranean inland: the Ustica Project. Nutr Metab Cardiovasc Dis, 2002; 12(5):267 -74.
  • 9Nawawi HM, Nor IM, Noor IM, et al. Current status of coronary risk factors amnng rural Malavs in Malaysia. J Cardiovasc Risk 2002;9(1); 17 -23.
  • 10Menotti A, Lanti M. Coronary risk factors predicting early and late coronary deaths. Heart 2003;89(1): 19 -24.

共引文献63

同被引文献33

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部